3 New Cardiology Devices Expand Outpatient Procedures

Approvals for smaller defibrillators, robotic cardiac surgeries, and intravascular lithotripsy could reshape ASC case mixes.

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

As more cardiovascular procedures move into outpatient settings, new device approvals are expanding what can safely be performed outside the hospital. These three cardiology technologies - a miniature defibrillation lead, robotic cardiac procedures using the da Vinci 5 surgical robot, and an intravascular lithotripsy system for peripheral artery disease - could influence case mix, capital planning, and competitive positioning for ASCs this year.

Why it matters

The shift of more complex cardiac procedures to outpatient settings like ASCs is driven by factors like improved device technology, patient preference, and cost savings. These new approvals could enable ASCs to take on a wider range of cardiovascular cases, potentially expanding their service lines and competitive positioning in local markets.

The details

The new defibrillation lead is the world's smallest, catheter-delivered device, allowing for less invasive implantation. Intuitive Surgical's da Vinci 5 robot received clearance for a range of cardiac procedures, from mitral valve repair to pacemaker lead placement. The SEISMIQ intravascular lithotripsy system uses acoustic pressure waves to break down calcified plaque without damaging soft tissue, improving blood flow in peripheral arteries.

  • In early 2026, electrophysiologists at the Texas Cardiac Arrhythmia Institute were the first in the nation to implant the new defibrillation lead.
  • Also in 2026, Intuitive Surgical received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot.
  • In 2026, vascular surgeon Nicolas Mouawad became the first in the U.S. to use the SEISMIQ intravascular lithotripsy system.

The players

Texas Cardiac Arrhythmia Institute

An electrophysiology center based in Austin, Texas that was the first to implant the new defibrillation lead.

Intuitive Surgical

A medical device company that received FDA clearance for cardiac procedures using its da Vinci 5 surgical robot.

Nicolas Mouawad, MD

A vascular surgeon who was the first in the U.S. to use the SEISMIQ intravascular lithotripsy system.

Got photos? Submit your photos here. ›

The takeaway

These new cardiology device approvals demonstrate how technological innovation is enabling more complex procedures to be safely performed in outpatient settings like ASCs. This could allow ASCs to expand their cardiovascular service lines and better compete with hospitals for certain cardiac cases, though it will also require significant capital investment and specialized expertise.